Y-mAbs Therapeutics (Y-mAbs Therapeutics) Net Margin % : -4.23% (As of Dec. 2023)

Y-mAbs Therapeutics Net Margin % Chart

Y-mAbs Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Margin %	Get a 7-Day Free Trial															3.68	-31.55	-30.37	-37.88	-4.23

Competitive Comparison of Y-mAbs Therapeutics's Net Margin %

For the Biotechnology subindustry, Y-mAbs Therapeutics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Y-mAbs Therapeutics's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Y-mAbs Therapeutics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Y-mAbs Therapeutics's Net Margin % falls into.

Y-mAbs Therapeutics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Y-mAbs Therapeutics's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Y-mAbs Therapeutics's Net Margin for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Y-mAbs Therapeutics  (NAS:YMAB) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Y-mAbs Therapeutics Net Margin % Related Terms

Thank you for viewing the detailed overview of Y-mAbs Therapeutics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Y-mAbs Therapeutics (Y-mAbs Therapeutics) Business Description